Avant Diagnostics, Inc. (‘Avant’) (OTC: AVDX), an oncology-focused healthcare technology company commercializing the proprietary Theralink proteomic biomarker platform announced positive clinical utility data, the confirmation of the clinical utility of the Theralink […]
TapImmune Enrolls 50% in Phase 2 Triple Negative Breast Cancer Study
TapImmune Inc, a clinical-stage immuno-oncology company specializing in the development of immunotherapies targeting women’s cancers, announced that it has enrolled 50% (40/80) of the patients in its randomized Phase 2 clinical study […]
OncoSec Advances IL 12 Immunotherapy for Melanoma
OncoSec Medical Incorporated (NASDAQ: ONCS) was recently granted FDA Fast Track designation to address the large population of non-responders to the current leading checkpoint inhibitor therapies for stage 4 melanoma. The leading […]
TapImmune Announces Fully-Funded Phase 2 Breast Cancer Vaccine Study
TapImmune, a clinical-stage immuno-oncology company developing peptide and gene-based immunotherapeutics for cancer and metastatic disease, announced the receipt of a $3.7 million grant from the U.S. Department of Defense (DoD). The grant […]
BIO-CEO Wraps Up 19th Annual Investor Conference
Now in its 19th year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. With a mission to support industry-wide […]
Angionetics Gene Therapy Candidate Selected for FDA Fast Track Program
Angionetics Inc. reported that the FDA has granted Fast Track designation for the Phase III clinical investigation of Generx (Ad5FGF-4) cardiovascular angiogenic gene therapy. Angionetics is a biotechnology company focused on the clinical and […]
Promaxo Receives $200k TEDCO Investment
The Maryland Technology Development Corporation (TEDCO) announced that two companies received $400,000 in funding through its Life Science Investment Fund (LSIF) – one of TEDCO’s Seed Investment Funds. TEDCO is the go-to source for entrepreneurial […]
Guided Therapeutics Enters into LuViva® Advanced Cervical Scan Agreement for China
Guided Therapeutics, the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached an agreement with Shandong Yaohua Medical Instrument Corporation in […]
